Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Validation of the chronic disease score-infectious disease (CDS-ID) for the prediction of hospital-associated clostridium difficile infection (CDI) within a retrospective cohort

Authors: Vanessa Stevens, Cathleen Concannon, Edwin van Wijngaarden, Jessina McGregor

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Aggregate comorbidity scores are useful for summarizing risk and confounder control in studies of hospital-associated infections. The Chronic Disease Score – Infectious Diseases (CDS-ID) was developed for this purpose, but it has not been validated for use in studies of Clostridium difficile Infection (CDI). The aim of this study was to assess the discrimination, calibration and potential for confounder control of CDS-ID compared to age alone or individual comorbid conditions.

Methods

Secondary analysis of a retrospective cohort study of adult inpatients with 2 or more days of antibiotic exposure at a tertiary care facility during 2005. Logistic regression models were used to predict the development of CDI up to 60 days post-discharge. Model discrimination and calibration were assessed using the c-statistic and Hosmer-Lemeshow (HL) tests, respectively. C-statistics were compared using chi-square tests.

Results

CDI developed in 185 out of 7,792 patients. The CDS-ID was a better standalone predictor of CDI than age (c-statistic 0.653 vs 0.609, P=0.04). The best discrimination was observed when CDS-ID and age were both used to predict CDI (c-statistic 0.680). All models had acceptable calibration (P>0.05).

Conclusion

The CDS-ID is a valid tool for summarizing risk of CDI associated with comorbid conditions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kyne L, Sougioultzis S, McFarland LV, Kelly CP: Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2002, 23 (11): 653-659. 10.1086/501989.CrossRef Kyne L, Sougioultzis S, McFarland LV, Kelly CP: Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2002, 23 (11): 653-659. 10.1086/501989.CrossRef
2.
go back to reference Bignardi GE: Risk factors for Clostridium difficile infection. J Hosp Infect. 1998, 40 (1): 1-15. 10.1016/S0195-6701(98)90019-6.CrossRefPubMed Bignardi GE: Risk factors for Clostridium difficile infection. J Hosp Infect. 1998, 40 (1): 1-15. 10.1016/S0195-6701(98)90019-6.CrossRefPubMed
3.
go back to reference Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE, Committee SL-T-C: Clostridium difficile in long-term-care facilities for the elderly. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2002, 23 (11): 696-703. 10.1086/501997.CrossRef Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE, Committee SL-T-C: Clostridium difficile in long-term-care facilities for the elderly. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2002, 23 (11): 696-703. 10.1086/501997.CrossRef
4.
go back to reference Vesta KS, Wells PG, Gentry CA, Stipek WJ: Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation. Am J Infect Control. 2005, 33 (8): 469-472. 10.1016/j.ajic.2005.06.004.CrossRefPubMed Vesta KS, Wells PG, Gentry CA, Stipek WJ: Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation. Am J Infect Control. 2005, 33 (8): 469-472. 10.1016/j.ajic.2005.06.004.CrossRefPubMed
5.
go back to reference McFarland LV, Surawicz CM, Stamm WE: Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990, 162 (3): 678-684. 10.1093/infdis/162.3.678.CrossRefPubMed McFarland LV, Surawicz CM, Stamm WE: Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990, 162 (3): 678-684. 10.1093/infdis/162.3.678.CrossRefPubMed
6.
go back to reference Nelson DE, Auerbach SB, Baltch AL, Desjardin E, Beck-Sague C, Rheal C, Smith RP, Jarvis WR: Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 1994, 15 (2): 88-94. 10.1086/646867.CrossRef Nelson DE, Auerbach SB, Baltch AL, Desjardin E, Beck-Sague C, Rheal C, Smith RP, Jarvis WR: Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 1994, 15 (2): 88-94. 10.1086/646867.CrossRef
7.
go back to reference Babyak MA: What You See May Not Be what You Get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosomatic Medicine. 2004, 66 (3): 411-421. 10.1097/01.psy.0000127692.23278.a9.PubMed Babyak MA: What You See May Not Be what You Get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosomatic Medicine. 2004, 66 (3): 411-421. 10.1097/01.psy.0000127692.23278.a9.PubMed
8.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40 (5): 373-383. 10.1016/0021-9681(87)90171-8.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40 (5): 373-383. 10.1016/0021-9681(87)90171-8.CrossRefPubMed
9.
go back to reference Horn SD, Chachich B, Clopton C: Measuring severity of illness: a reliability study. Med Care. 1983, 21 (7): 705-714. 10.1097/00005650-198307000-00004.CrossRefPubMed Horn SD, Chachich B, Clopton C: Measuring severity of illness: a reliability study. Med Care. 1983, 21 (7): 705-714. 10.1097/00005650-198307000-00004.CrossRefPubMed
10.
go back to reference Von Korff M, Wagner EH, Saunders K: A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology. 1992, 45 (2): 197-203. 10.1016/0895-4356(92)90016-G.CrossRefPubMed Von Korff M, Wagner EH, Saunders K: A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology. 1992, 45 (2): 197-203. 10.1016/0895-4356(92)90016-G.CrossRefPubMed
11.
go back to reference Labbé A-C, Poirier L, MacCannell D, Louie T, Savoie M, Béliveau C, Laverdière M, Pépin J: Clostridium difficile infections in a canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother. 2008, 52 (9): 3180-3187. 10.1128/AAC.00146-08.CrossRefPubMedPubMedCentral Labbé A-C, Poirier L, MacCannell D, Louie T, Savoie M, Béliveau C, Laverdière M, Pépin J: Clostridium difficile infections in a canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother. 2008, 52 (9): 3180-3187. 10.1128/AAC.00146-08.CrossRefPubMedPubMedCentral
12.
go back to reference McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann M-C, Harris AD: Utility of the chronic disease score and charlson comorbidity index as comorbidity measures for Use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol. 2005, 161 (5): 483-493. 10.1093/aje/kwi068.CrossRefPubMed McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann M-C, Harris AD: Utility of the chronic disease score and charlson comorbidity index as comorbidity measures for Use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol. 2005, 161 (5): 483-493. 10.1093/aje/kwi068.CrossRefPubMed
13.
go back to reference McGregor JC, Perencevich EN, Furuno JP, Langenberg P, Flannery K, Zhu J, Fink JC, Bradham DD, Harris AD: Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol. 2006, 59 (12): 1266-1273. 10.1016/j.jclinepi.2006.01.016.CrossRefPubMed McGregor JC, Perencevich EN, Furuno JP, Langenberg P, Flannery K, Zhu J, Fink JC, Bradham DD, Harris AD: Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol. 2006, 59 (12): 1266-1273. 10.1016/j.jclinepi.2006.01.016.CrossRefPubMed
14.
go back to reference Charlson ME, Ales KL, Simon R, MacKenzie CR: Why predictive indexes perform less well in validation studies: is It magic or methods?. Arch Intern Med. 1987, 147 (12): 2155-2161. 10.1001/archinte.1987.00370120091016.CrossRefPubMed Charlson ME, Ales KL, Simon R, MacKenzie CR: Why predictive indexes perform less well in validation studies: is It magic or methods?. Arch Intern Med. 1987, 147 (12): 2155-2161. 10.1001/archinte.1987.00370120091016.CrossRefPubMed
15.
go back to reference Schneeweiss S, Maclure M: Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol. 2000, 29 (5): 891-898. 10.1093/ije/29.5.891.CrossRefPubMed Schneeweiss S, Maclure M: Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol. 2000, 29 (5): 891-898. 10.1093/ije/29.5.891.CrossRefPubMed
16.
go back to reference Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E: Cumulative antibiotic exposures over time and the risk of clostridium difficile infection. Clin Infect Dis. 2011, 53 (1): 42-48. 10.1093/cid/cir301.CrossRefPubMed Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E: Cumulative antibiotic exposures over time and the risk of clostridium difficile infection. Clin Infect Dis. 2011, 53 (1): 42-48. 10.1093/cid/cir301.CrossRefPubMed
17.
go back to reference McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK: Ad Hoc clostridium difficile surveillance working G: recommendations for surveillance of clostridium difficile-associated disease. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2007, 28 (2): 140-145. 10.1086/511798.CrossRef McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK: Ad Hoc clostridium difficile surveillance working G: recommendations for surveillance of clostridium difficile-associated disease. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2007, 28 (2): 140-145. 10.1086/511798.CrossRef
18.
go back to reference Brunton LL, Lazo JS, Parker KL: Goodman & Gilman’s the pharmacological basis of therapeutics. 2006, New York: McGraw-Hill, Volume 11th Brunton LL, Lazo JS, Parker KL: Goodman & Gilman’s the pharmacological basis of therapeutics. 2006, New York: McGraw-Hill, Volume 11th
19.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988, 44 (3): 837-845. 10.2307/2531595.CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988, 44 (3): 837-845. 10.2307/2531595.CrossRefPubMed
20.
go back to reference Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982, 143 (1): 29-36.CrossRefPubMed Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982, 143 (1): 29-36.CrossRefPubMed
21.
go back to reference Lemeshow S, Hosmer DW: A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982, 115 (1): 92-106.PubMed Lemeshow S, Hosmer DW: A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982, 115 (1): 92-106.PubMed
22.
go back to reference Kramer AA, Zimmerman JE: Assessing the calibration of mortality benchmarks in critical care: the hosmer-lemeshow test revisited. Crit Care Med. 2007, 35 (9): 2052-2056. 10.1097/01.CCM.0000275267.64078.B0.CrossRefPubMed Kramer AA, Zimmerman JE: Assessing the calibration of mortality benchmarks in critical care: the hosmer-lemeshow test revisited. Crit Care Med. 2007, 35 (9): 2052-2056. 10.1097/01.CCM.0000275267.64078.B0.CrossRefPubMed
23.
go back to reference Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ: Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007, 45 (12): 1543-1549. 10.1086/523582.CrossRefPubMed Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ: Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007, 45 (12): 1543-1549. 10.1086/523582.CrossRefPubMed
24.
go back to reference Dial S, Delaney JA, Barkun AN, Suissa S: Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA: the journal of the American Medical Association. 2005, 294 (23): 2989-2995. 10.1001/jama.294.23.2989.CrossRefPubMed Dial S, Delaney JA, Barkun AN, Suissa S: Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA: the journal of the American Medical Association. 2005, 294 (23): 2989-2995. 10.1001/jama.294.23.2989.CrossRefPubMed
25.
go back to reference Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V: Emergence of fluoroquinolones as the predominant risk factor for clostridium difficile–associated diarrhea: a cohort study during an epidemic in quebec. Clin Infect Dis. 2005, 41 (9): 1254-1260. 10.1086/496986.CrossRefPubMed Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V: Emergence of fluoroquinolones as the predominant risk factor for clostridium difficile–associated diarrhea: a cohort study during an epidemic in quebec. Clin Infect Dis. 2005, 41 (9): 1254-1260. 10.1086/496986.CrossRefPubMed
26.
go back to reference Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C: Risk factors for Clostridium difficile toxin-associated diarrhea. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 1990, 11 (6): 283-290. 10.1086/646173.CrossRef Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C: Risk factors for Clostridium difficile toxin-associated diarrhea. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 1990, 11 (6): 283-290. 10.1086/646173.CrossRef
27.
go back to reference Dial S, Delaney JAC, Schneider V, Suissa S: Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. Canadian Medical Association journal. 2006, 175 (7): 745-748. 10.1503/cmaj.060284.CrossRefPubMedPubMedCentral Dial S, Delaney JAC, Schneider V, Suissa S: Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. Canadian Medical Association journal. 2006, 175 (7): 745-748. 10.1503/cmaj.060284.CrossRefPubMedPubMedCentral
28.
go back to reference Stevens V, Dumyati G, Brown J, van Wijngaarden E: Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure. Pharmacoepidemiology and Drug Safety. 2011, 20 (10): 1035-1042. 10.1002/pds.2198.CrossRefPubMed Stevens V, Dumyati G, Brown J, van Wijngaarden E: Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure. Pharmacoepidemiology and Drug Safety. 2011, 20 (10): 1035-1042. 10.1002/pds.2198.CrossRefPubMed
29.
go back to reference Akkerman AE, van der Wouden JC, Kuyvenhoven MM, Dieleman JP, Verheij TJM: Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities. J Antimicrob Chemother. 2004, 54 (6): 1116-1121. 10.1093/jac/dkh480.CrossRefPubMed Akkerman AE, van der Wouden JC, Kuyvenhoven MM, Dieleman JP, Verheij TJM: Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities. J Antimicrob Chemother. 2004, 54 (6): 1116-1121. 10.1093/jac/dkh480.CrossRefPubMed
30.
go back to reference Junior M, Correa L, Marra A, Camargo L, Pereira C: Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study. BMC Infect Dis. 2007, 7 (1): 88-10.1186/1471-2334-7-88.CrossRefPubMedPubMedCentral Junior M, Correa L, Marra A, Camargo L, Pereira C: Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study. BMC Infect Dis. 2007, 7 (1): 88-10.1186/1471-2334-7-88.CrossRefPubMedPubMedCentral
31.
go back to reference McCarthy DM: Proton pump inhibitor use and Clostridium difficile colitis: cause or coincidence?. J Clin Gastroenterol. 2012, 46 (5): 350-353. 10.1097/MCG.0b013e31824b228f.CrossRefPubMed McCarthy DM: Proton pump inhibitor use and Clostridium difficile colitis: cause or coincidence?. J Clin Gastroenterol. 2012, 46 (5): 350-353. 10.1097/MCG.0b013e31824b228f.CrossRefPubMed
32.
go back to reference Schmidt ML, Gilligan PH: Clostridium difficile testing algorithms: what is practical and feasible?. Anaerobe. 2009, 15 (6): 270-273. 10.1016/j.anaerobe.2009.10.005.CrossRefPubMed Schmidt ML, Gilligan PH: Clostridium difficile testing algorithms: what is practical and feasible?. Anaerobe. 2009, 15 (6): 270-273. 10.1016/j.anaerobe.2009.10.005.CrossRefPubMed
Metadata
Title
Validation of the chronic disease score-infectious disease (CDS-ID) for the prediction of hospital-associated clostridium difficile infection (CDI) within a retrospective cohort
Authors
Vanessa Stevens
Cathleen Concannon
Edwin van Wijngaarden
Jessina McGregor
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-150

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine